Bio-Rad Laboratories | BIO - Ebitda


Bio-Rad Laboratories reported $119.9M in EBITDA for its fiscal quarter ending in September of 2026.





Ebitda Change Date
Abbott USD 2.43B 844M Mar/2026
Agilent USD 577M 77M Jun/2026
Becton, Dickinson and Co. USD 1.71B 1B Jun/2026
Bio Techne USD 115.94M 763K Jun/2026
Bio-Rad Laboratories USD 119.9M 475.4M Sep/2026
Bruker USD 143.2M 33.2M Jun/2026
Charles River Laboratories USD 298.04M 25.1M Sep/2026
Danaher USD 2.1B 257M Sep/2026
General Electric Aerospace USD 3.32B 265M Sep/2026
Illumina USD 330M 80M Jun/2026
IQVIA Holdings USD 1.03B 38M Sep/2026
Laboratory Of America USD 674.3M 93.4M Sep/2026
Merck USD 1.42B 2.97B Jun/2026
Mettler Toledo International USD 366.1M 43.45M Sep/2026
Myriad Genetics USD 14.3M 4M Dec/2025
OraSure Technologies USD -17.7M 4.06M Dec/2025
Pacific Biosciences Of California USD -35.4M 5.78M Sep/2025
Quest Diagnostics USD 627M 21M Sep/2026
Repligen USD 43.84M 70K Sep/2026
Revvity USD 227.55M 629K Sep/2026
Roche Holding CHF 13.43B 744M Jun/2026
Siemens EUR 4.57B 366M Sep/2026
Standard Biotools USD -6.56M 1.45M Jun/2026
Thermo Fisher Scientific USD 3.79B 244M Sep/2026
Tosoh JPY 39.13B 286M Dec/2024
Waters USD 554M 158M Sep/2026